Donna H. Ryan, MD is Professor Emerita at Pennington Biomedical Research Center (Baton Rouge, LA) and a world-renowned obesity medicine researcher, past president of The Obesity Society and current President of World Obesity Federation.
I think the emergence of these oral medications and studies like AttainMaintain that show how to transition from an injectable to an oral are going to help with that.
We are more now interested in the organ protective effect of this medication, not just for BMI or weight reduction itself.
We value your privacy
We use cookies to understand how you use our platform and to improve your experience. Click “Accept All” to consent, or “Decline non-essential” to opt out of non-essential cookies. Read our Privacy Policy.